comparemela.com

Latest Breaking News On - Troy talkkari - Page 2 : comparemela.com

Willow Biosciences Reports Fourth Quarter and 2020 Year End Results and Operational Update

Willow Biosciences Reports Fourth Quarter and 2020 Year End Results and Operational Update
newswire.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswire.ca Daily Mail and Mail on Sunday newspapers.

Willow Biosciences Announces Exercise of Over-Allotment Option and [ ]

19 febbraio 2021 17:28 Fonte: Adnkronos #chimica-e-farmacia VANCOUVER, BC, Feb. 19, 2021 /PRNewswire/  Willow Biosciences Inc. ( Willow or the  Company ) (TSX: WLLW) (TSX: WLLW.WT) (OTCQX: CANSF) is pleased to announce that it has closed its previously announced upsized bought deal offering of 17,424,800 common shares (the Common Shares ) of the Company at a price of $1.65 per Common Share, which includes 2,272,800 Common Shares issued pursuant to the exercise in full of the over-allotment option, for aggregate gross proceeds of approximately $28.75 million (the Offering ). Participation in the Offering was comprised primarily of existing cornerstone shareholders and new institutional buyside funds. Net proceeds from the Offering are expected to be used to help access new markets for the Company s cannabinoid portfolio, expedite the commercialization of new cannabinoids, access additional manufacturing capacity, working capital and general corporate purposes.

Willow Biosciences Announces Increase to Bought Deal Offering from $20 0 Million to $25 0 Million

Willow Biosciences Announces $20 0 Million Bought Deal Offering

Willow Biosciences Advances Its Work On THC; Plans To Launch In The [ ]

19 gennaio 2021 13:02 Fonte: Adnkronos #altro VANCOUVER, BC, Jan. 19, 2021 /PRNewswire/ Willow Biosciences Inc. ( Willow or the Company ) (TSX: WLLW) (OTCQX: CANSF) is pleased to announce that it has advanced its work on its proprietary yeast strain for production of Tetrahydrocannabinol ( THC ), and plans to commercially launch in the Canadian market. We are excited to announce our proprietary THC yeast biosynthesis production process for launch in the Canadian market, said Trevor Peters, Willow s President and Chief Executive Officer. Our platform technology enables us to produce a variety of cannabinoids and leverage our previous work on CBG. From conversations with prospective customers in Canada, we believe that there is significant demand for consistent, high-purity THC. The flavourless, odorless attributes of our finished product make it suitable as a core ingredient for the cannabis 2.0 market in Canada. There is also strong demand for a more sustainable and en

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.